Skip to main content
eScholarship
Open Access Publications from the University of California

Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade

  • Author(s): Wu, X
  • Zhang, W
  • Font-Burgada, J
  • Palmer, T
  • Hamil, AS
  • Biswas, SK
  • Poidinger, M
  • Borcherding, N
  • Xie, Q
  • Ellies, LG
  • Lytle, NK
  • Wu, LW
  • Fox, RG
  • Yang, J
  • Dowdy, SF
  • Reya, T
  • Karin, M
  • et al.

Published Web Location

http://www.pnas.org/content/111/38/13870.long
No data is associated with this publication.
Abstract

Metastatic spread is the leading cause of cancer mortality. Breast cancer (BCa) metastatic recurrence can happen years after removal of the primary tumor. Here we show that Ubc13, an E2 enzyme that catalyzes K63-linked protein polyubiquitination, is largely dispensable for primary mammary tumor growth but is required for metastatic spread and lung colonization by BCa cells. Loss of Ubc13 inhibited BCa growth and survival only at metastatic sites. Ubc13 was dispensable for transforming growth factor β (TGFβ)-induced SMAD activation but was required for activation of non-SMAD signaling via TGFâ-activating kinase 1 (TAK1) and p38, whose activity controls expression of numerous metastasis promoting genes. p38 activation restored metastatic activity to Ubc13-deficient cells, and its pharmacological inhibition attenuated BCa metastasis in mice, suggesting it is a therapeutic option for metastatic BCa.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item